Infinium Pharmachem IPO

Infinium Pharmachem IPO will open for subscription from 31 March 2023. the company aims for an issue size of ₹25.26 Cr through this IPO.

About Company

Incorporated in 2003, Infinium Pharmachem aims to manufacture and supply Iodine, Iodine Derivatives, and Active Pharmaceutical Ingredients (APIs). The company undertakes contract research and manufacturing services to provide customized and fully confidential solutions to its clients. Today, its manufacturing capabilities and technical expertise has allowed it to efficiently cater to numerous industries such as pharmaceutical & biotech, specialty & Performance chemicals, agrochemicals, human health, animal health, cosmetics, sanitation, electrical, electronics, and much more. Its manufacturing plant in Gujarat, provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.

Basic details about the company

Full nameInfinium Pharmachem Limited
Company Website

The objective of the Issue

  • Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
  • 2. Repayment of some of the existing loans and expansion of units.
  • 3. To meet incremental working capital requirements.
  • 4. To meet public issue expenses.

IPO Timetable

IPO Opening date31 March 2023
IPO Closing05 April 2023
Basis of Allotment11 April 2023
Initiation Refund12 April 2023
Credit to Demat Account13 April 2023
Listing Date17 April 2023

IPO details

Issue typeFixed Price Issue IPO
IPO issue size₹25.26 Cr – 1,875,000 shares
Fresh Issue₹25.26 Cr – 1,875,000 shares
Offer for saleNil
Face value₹10 per share
Offer Price₹135 per share
Lot size1000 Shares
Retail Allocation50%
Listing ExchangeNSE SME

IPO Lot Size

Retail (Min)11000₹135,000
Retail (Max)11000₹135,000
HNI (Min)22,000₹270,000

Reservation Details

QIB Shares OfferedNil
NII (HNI) Shares Offered50%
Retail Shares Offered50%

Financial Performance

 FY 2020FY 2021FY 2022H1 FY 2023
Net income0.872.736.696.0
(Amount in ₹ Crors)

Valuations & Margins

FY 2020FY 2021FY 2022
PE ratio11.24
RONW (%)21.9938.8046.61
ROCE (%)
EBITDA (%)7.887.9111.07

Company Promoters

  • Mr. Sanjaykumar Viththalbhai Patel
  • Mr. Pravin Bhadabhai Madhani
  • Mr. Mitesh Lavjibhai Chikhaliya

Promoter Holding

Pre Issue Share Holding100%
Post Issue Share Holding

Lead Manager(s)

  • Swastika Investmart Ltd

IPO Registrar

Office No. S6-2, 6th Floor,
Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East,
Mumbai – 400 093
Telephone: +91 22 6263 8200

Contact Details

Suite 205, Sigma Prime, 2nd Floor,
Nr. Sardar Patel Statue Vallabh Vidhyanagar,
Dist. Anand – 388120, Gujarat
Phone: +91 (2692) 238849, 238850, 297446

Allotment Status

Infinium Pharmachem IPO allotment status will be available on Bigshare Services’ website. Click on Bigshare Services weblink to get allotment status.

Final thoughts

Infinium Pharmachem IPO is going to hit Dalal street soon. applying for an IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.

Happy Investing

Leave a Comment

Your email address will not be published. Required fields are marked *